Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

1.04USD
24 May 2013
Price Change (% chg)

$0.05 (+5.05%)
Prev Close
$0.99
Open
$0.99
Day's High
$1.08
Day's Low
$0.96
Volume
693,053
Avg. Vol
330,261
52-wk High
$9.43
52-wk Low
$0.75

CLSN.OQ

Chart for CLSN.OQ

About

Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical... (more)

Overall

Beta: 1.37
Market Cap (Mil.): $53.68
Shares Outstanding (Mil.): 51.61
Dividend: --
Yield (%): --

Financials

  CLSN.OQ Industry Sector
P/E (TTM): -- 46.63 34.30
EPS (TTM): -0.76 -- --
ROI: -113.42 1.55 18.43
ROE: -139.26 2.77 19.30
Search Stocks

BRIEF-Celsion up in premarket trading after comments

NEW YORK, April 23 - Celsion Corp : * Up 17 percent in premarket trading after comments

23 Apr 2013

Celsion plunges 80 percent as liver cancer therapy fails trial

- Celsion Corp shares plunged by more than 80 percent after a late-stage study of the company's experimental liver cancer treatment ThermoDox failed to meet the main goal of increasing patients' survival without worsening their cancer.

31 Jan 2013

BRIEF-Celsion plunges after therapy fails to meet goal

NEW YORK, Jan 31 - Celsion Corp : * Shares plunge 83 percent in premarket, cancer therapy fails to meet trial

31 Jan 2013

Celsion shares jump after bullish online report

- Shares of Celsion Corp jumped 17 percent on Monday after an investment website said the stock could rise significantly if results from a key study of its ThermoDox liver cancer treatment are positive.

26 Nov 2012

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Wright Reports
$460.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks